TYPE: Prescription
BRAND: Sunitinib Rowex
ACTIVE INGREDIENT: sunitinib
STRENGTH, PACK SIZE & GMS CODE:
Sunitinib Rowex 12.5mg Hard Capsules x 28 (89084)Sunitinib Rowex 25mg Hard Capsules x 28 (89085)
Sunitinib Rowex 50mg Hard Capsules x 28 (89086)
INDICATION:
Therapeutic indications:Gastrointestinal stromal tumour (GIST)
Sunitinib Rowex is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (GIST) in adults after failure of imatinib treatment due to resistance or intolerance.
Metastatic renal cell carcinoma (MRCC)
Sunitinib Rowex is indicated for the treatment of advanced/metastatic renal cell carcinoma (MRCC) in adults.
Pancreatic neuroendocrine tumours (pNET)
Sunitinib Rowex is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pNET) with disease progression in adults.
Sunitinib Rowex 12.5mg Hard Capsules SPC and Patient Information Leaflet
Sunitinib Rowex 25mg Hard Capsules SPC and Patient Information Leaflet
Sunitinib Rowex 50mg Hard Capsules SPC and Patient Information Leaflet
